PTC Therapeutics, Inc. Accounts Payable, Related Parties
PTC Therapeutics, Inc. (PTCT) had Accounts Payable, Related Parties of $3.90 million as of 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent · last filed 2018-08-07
- 2018-06-30: Accounts Payable, Related Parties $3.90M.
| Period end | Accounts Payable, Related Parties |
|---|---|
| 2018-06-30 | $3.90M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |